Eli Lilly rebuked by the UK’s PMCPA for its unbalanced Cialis promotion
스크롤 이동 상태바
Eli Lilly rebuked by the UK’s PMCPA for its unbalanced Cialis promotion
기자명
메디칼라이터팀
입력 2008.11.17 00:00
수정 2008.11.17 08:39
댓글 0
The PMCPA, U.K."s watchdog of the pharmaceutical market, is reprimanding Eli Lilly for promoting its anti-erectile dysfunction drug without presenting information on the side-effects or risks, and in a way that encourages patients to seek a prescription for Cialis (tadalafil) . Meanwhile Eli Lilly corrected its campaign last month.